General Information of the Compound
| Compound ID |
CP0407479
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3S)-3-amino-4-[[(1R,4S,10S,13S,16S,19S,22S,25R,30R,33S,36S,39S,42S,45S,48S,51R,54S,57S,60S,63S,69S,72R,77R,80S,86S,89S,92S,95S)-30-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]carbamoyl]-22,36,95-tris(4-aminobutyl)-16,60-bis(2-amino-2-oxoethyl)-86-benzyl-45,69,92-tris(3-carbamimidamidopropyl)-4,13,19-tris(carboxymethyl)-42-[(1R)-1-hydroxyethyl]-48-(hydroxymethyl)-39-(1H-imidazol-5-ylmethyl)-33-(1H-indol-3-ylmethyl)-57,80-bis(2-methylpropyl)-89-(2-methylsulfanylethyl)-2,3a,5,11,14,17,20,23,32,35,38,41,44,47,50,53,56,59,62,68,71,78,81,84,87,90,93,96-octacosaoxo-54-propan-2-yl-a,27,28,74,75,99-hexathia-2a,3,6,12,15,18,21,24,31,34,37,40,43,46,49,52,55,58,61,67,70,79,82,85,88,91,94,97-octacosazapentacyclo[49.46.4.225,72.06,10.063,67]trihectan-77-yl]amino]-4-oxobutanoic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C174H265N53O47S7
|
||||||||||||||||||
| Molecular Weight |
4075.827
|
||||||||||||||||||
| Canonical SMILES |
CSCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CSSC[C@@H]2NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc4cnc[nH]4)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC1=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N3)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC2=O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C174H265N53O47S7/c1-86(2)62-109-141(244)194-77-131(233)196-111(65-92-34-15-12-16-35-92)149(252)203-106(51-61-275-10)147(250)198-104(42-27-56-190-172(183)184)142(245)197-102(40-21-25-54-177)145(248)218-124-82-279-281-84-126-163(266)216-120(78-228)158(261)201-105(43-28-57-191-173(185)186)148(251)225-138(90(9)229)169(272)214-114(68-95-76-189-85-195-95)151(254)199-100(38-19-23-52-175)144(247)209-113(67-94-75-193-99-37-18-17-36-97(94)99)150(253)220-122(159(262)202-101(39-20-24-53-176)143(246)208-112(66-93-47-49-96(230)50-48-93)157(260)224-136(88(5)6)167(270)205-108(139(182)242)64-91-32-13-11-14-33-91)80-277-280-83-125(219-146(249)103(41-22-26-55-178)200-154(257)117(72-133(236)237)211-152(255)115(70-129(180)231)210-155(258)118(73-134(238)239)213-166(269)128-46-31-60-227(128)171(274)119(74-135(240)241)215-162(124)265)164(267)221-123(81-278-276-79-121(161(264)206-109)217-140(243)98(179)69-132(234)235)160(263)204-107(44-29-58-192-174(187)188)170(273)226-59-30-45-127(226)165(268)212-116(71-130(181)232)153(256)207-110(63-87(3)4)156(259)223-137(89(7)8)168(271)222-126/h11-18,32-37,47-50,75-76,85-90,98,100-128,136-138,193,228-230H,19-31,38-46,51-74,77-84,175-179H2,1-10H3,(H2,180,231)(H2,181,232)(H2,182,242)(H,189,195)(H,194,244)(H,196,233)(H,197,245)(H,198,250)(H,199,254)(H,200,257)(H,201,261)(H,202,262)(H,203,252)(H,204,263)(H,205,270)(H,206,264)(H,207,256)(H,208,246)(H,209,247)(H,210,258)(H,211,255)(H,212,268)(H,213,269)(H,214,272)(H,215,265)(H,216,266)(H,217,243)(H,218,248)(H,219,249)(H,220,253)(H,221,267)(H,222,271)(H,223,259)(H,224,260)(H,225,251)(H,234,235)(H,236,237)(H,238,239)(H,240,241)(H4,183,184,190)(H4,185,186,191)(H4,187,188,192)/t90-,98+,100+,101+,102+,103+,104+,105+,106+,107+,108+,109+,110+,111+,112+,113+,114+,115+,116+,117+,118+,119+,120+,121+,122+,123+,124+,125+,126+,127+,128+,136+,137+,138+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
MHBIVXGTRINGBZ-GDCYEXNISA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03043, Sodium channel protein type 4 subunit alpha
Protein ID: PT01105, Sodium channel protein type 5 subunit alpha
Protein ID: PT01000, Sodium channel protein type 9 subunit alpha